Short QT syndrome is a very rare genetic entity generally caused by an increase in function in some cardiac ion channels, which leads to an abnormal shortening of cardiac repolarization. It is associated with a high predisposition to ventricular arrhythmias, and patients may present syncope, cardiac arrest or sudden death. As in the case of long QT syndrome, these can be the first manifestations of the disease and can occur at any age.
The probability of detecting a pathogenic mutation when a patient has been diagnosed with short QT syndrome has not been clearly established, although it is estimated to be close to 25%.
How to order
1. Download & fill out
Please cover as many fields as possible in both documents
2. Sample collection
Three sample types: saliva, peripheral blood or genomic DNA
3. Pack the sample
Please pack the sample in a way to prevent leakage
4. Send the sample & the request
Please schedule the delivery for Mon–Thur: 8am – 5pm
5. Result: the report
Via: Client Site HIC / Client Site Imegen / Certified email
"*" indicates required fields
Turnaround time (TAT): 4 weeks
Ref. S-201906401
Priority Genes : Genes where there is sufficient evidence (clinical and functional) to consider them associated with the disease; they are included in the clinical practice guidelines.
Secondary Genes: Genes related to the disease, but with a lower level of evidence or that constitute sporadic cases.
* Candidate Genes: Not enough evidence in humans, but potentially associated with the disease.
Panel that include short QT syndrome genes
Panel that include short QT syndrome genes
Panel that include short QT syndrome genes
